Trials / Unknown
UnknownNCT04660773
PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS
NARROW BAND UVB PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY PRURITIS IN END STAGE RENAL DISEASE PATIENTS
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Patients will be randomly assigned into 2 groups: 1. Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months. 2. Group B: (20 patients) will receive pregabalin oral therapy (50mg after each dialysis session) for 2 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NB UVB phototherapy | ultraviolet phototherapy sessions |
| DRUG | Pregabalin | oral medication |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2020-12-09
- Last updated
- 2021-07-26
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04660773. Inclusion in this directory is not an endorsement.